Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
MEXC Spot Market Adds Ondo Tokenized Plug Power, iShares MSCI South Korea and Japan ETFs
-
MEXC Launches VVIP System Powered by M-Score, Redefining Elite Access Beyond Asset Thresholds
-
MEXC Launches Mezo (MEZO) Airdrop+ Event with $50,000 in MEZO and 15,000 USDT in Rewards
-
Acuity Reports Fiscal 2026 Second-Quarter Results
-
Global Net Lease, Inc. Announces Retirement of Two Board Members
-
Nasdaq-Listed ZeroStack Corp. Makes $107 Million Institutional Commitment To Increase Strategic Position in 0G Token Ecosystem
-
LoJack by Solera Renews Hendrick Motorsports NASCAR Cup Series Sponsorship Through 2028
-
The Board of Directors of Harvia Plc have decided on a new performance period for the Long-term Performance Share Plan for the key employees
-
Sfil: Annual Financial Report 2025 now available
-
Man Group PLC : Form 8.3 - A consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
-
Arch Biopartners Closes Non-Brokered Private Placement
-
Man Group PLC : Form 8.3 - JTC Plc
-
Form 8.5 (EPT/RI) - Alternative Income REIT Plc
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
Form 8.5 (EPT/RI) - PPHE Hotel Group Limited
-
In the Name of Elegance, a Dialogue with the Future | LEPAS Set to Unveil in Milan
-
Form 8.5 (EPT/RI) - Kore Potash Plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
-
Dimensional Fund Advisors Ltd. : Form 8.3 - CAPRICORN ENERGY PLC - Ordinary Shares
-
TNQTech, a Lumina Datamatics Company, Certified as a Great Place to Work®
-
Top Ships Announces Filing of 2025 Annual Report on Form 20-F
-
Futu Announces Cash Dividend
-
Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
-
Priovant Expands Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP)
-
Roivant Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
-
SmartD Technologies Secures $15M CAD Financing Round
-
Axi Select Marks Major Milestone as Fourth Asia-Based Trader Achieves Pro M Status and $1M Funded Account
-
Half-year Financial Report
-
MyGevity Announces Nationwide Launch of Integrated Health Data Platform
-
Solvac publishes its 2025 Annual Report
-
Endeavour To Announce Its Q1 2026 Results On 30 April 2026
-
Form 8.5 (EPT/RI)-NCC Group plc
-
Sihoo Launches Doro C300 Pro V2: The First Full-Body Adaptive Ergonomic Chair That Ends "Loss of Support" in Prolonged Sitting
-
Sihoo Launches Doro C300 Pro V2: The First Full-Body Adaptive Ergonomic Chair That Ends "Loss of Support" in Prolonged Sitting
-
Share Buyback Transaction Details March 26 – April 1, 2026
-
ProMeritum announces new Senior Economist for LatAm and new focus on region
-
LawFairy Goes Live, Launching Deterministic Legal Intelligence Platform for UK Immigration
-
Programme for the issuance of Collateralised ETP Securities
-
Record-Breaking Black Tech COFE+ Intelligent Coffee Robot Sold in 65 Countries
-
Solomon Global wins ‘Best UK Gold Bullion Dealer’ at ADVFN International Financial Awards 2026
-
Breaking Brand Licensing Records: License Global Unveils 2026’s Top Agents and Industry Trends
-
CallTower Announces Strategic Investment from Court Square Capital Partners
-
Municipality Finance issues EUR 50 million zero coupon notes under its MTN programme
-
AS Ekspress Grupp to acquire a training company in Latvia
-
Accor Welcomes Aimie, a New Team Member and Performance Engine for Finance
-
Michelin: Disclosure of trading in own shares - April 2nd, 2026
-
Pulsar Helium Announces Officer Appointment
-
Impact Analytics Announces Strategic Partnership with AllSaints
-
Kalmar supplies hybrid straddle carriers to PSA Antwerp
-
JDE Peet’s transfers shares to participants under its employee incentive plans
